Stages of hypertension and the frequency of the appointment of certain groups of cardiac drugs in patients at the annual stage of pacing
Vol 71 No 2–3 (2016), Therapy
Vol 71 No 2–3 (2016)

Stages of hypertension and the frequency of the appointment of certain groups of cardiac drugs in patients at the annual stage of pacing

Therapy
Published March 7, 2020
T. Derienko
Kharkiv National University named after V.N. Karazin
D. Volkov
State Institution “Institute of General and Emergency Surgery of the National Academy of Medical Sciences of Ukraine named after V.T. Zaitsev", Kharkov
D. Lopyn
State Institution “Institute of General and Emergency Surgery of the National Academy of Medical Sciences of Ukraine named after V.T. Zaitsev", Kharkov
N. Yabluchansky
Kharkiv National University named after V.N. Karazin
PDF (Русский)

Keywords

pacing
hypertension
drug therapy
the annual period of observation

How to Cite

Derienko , T., Volkov , D., Lopyn , D., & Yabluchansky , N. (2020). Stages of hypertension and the frequency of the appointment of certain groups of cardiac drugs in patients at the annual stage of pacing. Medicine Today and Tomorrow, 71(2–3), 21–25. Retrieved from https://msz.knmu.edu.ua/article/view/428
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

We observed 131 patients (70 men and 61 women) aged 69,5±11,6 at the annual stage of drug therapy after implantation of pacemakers in the DDD / DDDR modes, VVI / VVIR and CRT-P / CRT-D. We took into account the frequency of the appointment of major groups of cardiac drugs in patients with a pacemaker at the annual stage of observation, depending on the stage of hypertension. Results showed that frequency of diuretics, β-blockers, calcium channel blockers, ACE inhibitors, antiarrhythmics, and statins increased after implantation of a pacemaker. The frequency of the appointment of drugs was determined by the stage of hypertension, and the annual follow-up the stage III of hypertension required more frequent, than the stage II of hypertension, appointment of diuretics, blockers, ACE inhibitors, antiplatelet agents and inhibitors of HMG-CoA reductase. Patients with implanted pacemaker require individualized medication approach, taking into account the stage of hypertension.

PDF (Русский)

References

Ramirez A. Implantation of cardiac rhythm devices during concomitant anticoagulation or antiplatelet therapy / A. Ramirez, T. Wall, M. Schmidt [et al.] // Expert Rev Cardiovasc Ther. – 2011. – № 9 (5). – p. 609–614.

Kolomytseva I. N. Functional class of chronic heart failure and supportive drug therapy in patients at the annual stage pacing / I. N. Kolomytseva //Canadian Journal of Education and Engineering. – 2015. – № 2 (12). – P. 569–578.

Shanina I. V. Frequency of detached cardiac drugs prescribing in patients of different classes QRS complex duration on the permanent pacing background / I. V. Shanina, D. E. Volkov // The Journal of V. N. Karazin Kharkiv National University, series "Medicine" – 2014. – № 27. – P. 33–37.

Рекомендації Української Асоціації кардіологів з профілактики та лікування артеріальної гіпертензії. Посібник до Національної програми профілактики і лікування артеріальної гіпертензії. – К. : ПП ВМБ, 2008. – 80 с. 4е видання, виправлене і доповнене. – C. 8–11.

Maltseva M.S. Prognostic value of QTc interval duration in medical management of patients after implantation of the pacemaker and CRT devices: avtoref. dis. for the sciences. the degree of PhD. : special. 14. 01.11 "cardiology"/. - Kharkiv, 2015. – 25 p.

Kolomytseva I.N. Functional class of chronic heart failure and supportive drug therapy in patients at the annual stage pacing./I.N. Kolomytseva // Canadian Journal of Education and Engineering. – 2015. – № 2 (12). – P. 569–578.

Cardiac pacing strategies and post-implantation risk of atrial fibrillation and heart failure events in sinus node dysfunction patients: a collaborative analysis of over 6000 patients / S. Chen, Z. Wang, M. Kiuchi [et.al.]. // Clin Res Cardiol. – 2016. – № 25. – P. 10–112.

Prevention of syncope through permanent cardiac pacing in patients with bifascicular block and syncope of unexplained origin: the PRESS study / M. Santini, A. Castro, F. Giada [et.al]. // Circ Arrhythm Electrophysiol. – 2013. – № 6 (1). – P. 7–101.

Usefulness of statins in preventing atrial fibrillation in patients with permanent pacing systematic review/ Santangeli P., Ferrante G., Pelargonio G. [et.al.] // Europace. – 2010. – № 12. – P. 649–654.